2hnt
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2hnt.jpg|left|200px]] | + | [[Image:2hnt.jpg|left|200px]] |
- | + | ||
- | '''CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN''' | + | {{Structure |
+ | |PDB= 2hnt |SIZE=350|CAPTION= <scene name='initialview01'>2hnt</scene>, resolution 2.5Å | ||
+ | |SITE= | ||
+ | |LIGAND= | ||
+ | |ACTIVITY= | ||
+ | |GENE= | ||
+ | }} | ||
+ | |||
+ | '''CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 10: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | 2HNT is a [ | + | 2HNT is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HNT OCA]. |
==Reference== | ==Reference== | ||
- | Crystallographic structure of human gamma-thrombin., Rydel TJ, Yin M, Padmanabhan KP, Blankenship DT, Cardin AD, Correa PE, Fenton JW 2nd, Tulinsky A, J Biol Chem. 1994 Sep 2;269(35):22000-6. PMID:[http:// | + | Crystallographic structure of human gamma-thrombin., Rydel TJ, Yin M, Padmanabhan KP, Blankenship DT, Cardin AD, Correa PE, Fenton JW 2nd, Tulinsky A, J Biol Chem. 1994 Sep 2;269(35):22000-6. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/8071320 8071320] |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
Line 19: | Line 28: | ||
[[Category: serine protease]] | [[Category: serine protease]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 17:19:15 2008'' |
Revision as of 15:19, 20 March 2008
| |||||||
, resolution 2.5Å | |||||||
---|---|---|---|---|---|---|---|
Coordinates: | save as pdb, mmCIF, xml |
CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN
Contents |
Overview
In an effort to prepare crystals and determine the structure of alpha-thrombin complexed to a synthetic peptide inhibitor (MDL-28050) of the hirudin 54-65 COOH-terminal region, it was discovered that the crystals were not those of the complex but of gamma-thrombin. Gel electrophoresis studies revealed that autolytic degradation had occurred prior to crystallization. NH2-terminal sequence analysis of these autolytic fragments confirmed the gamma-thrombin product (cleavages at Arg75-Tyr76 and/or Arg77A-Asn78, and Lys149E-Gly150; chymotrypsinogen numbering) with a minor amount of another autolysis product, beta-thrombin (first two cleavages only). The final structure has an R-factor of 0.156 for 7.0-2.5-A data, and includes 186 water molecules. A comparison of gamma-thrombin with the thrombin structure in the alpha-thrombin-hirugen complex revealed that the two structures agreed well (r.m.s. delta = 0.39 A for main chain atoms). These structures possess uninhibited active sites where the disposition of the catalytic triad residues is nearly identical. The electron density in the vicinity of the gamma-thrombin cleavage regions is poor, and only becomes well-defined several residues prior to and after the actual cleavage sites. The extensive disorder evoked by beta-cleavage(s) in the Lys70-Glu80 loop region indicates that this part of the molecule is severely disrupted by autolysis and is the reason exosite functions are dramatically impaired in beta-and gamma-thrombin. Since autolysis did not lead to a major reorganization of the folded structure of alpha-thrombin, the likely structural features of the interaction of thrombin substrate with thrombin enzyme during beta-cleavage have been modeled by docking the exosite region of one molecule at the active site of another.
Disease
Known diseases associated with this structure: Dysprothrombinemia OMIM:[176930], Hyperprothrombinemia OMIM:[176930], Hypoprothrombinemia OMIM:[176930]
About this Structure
2HNT is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Crystallographic structure of human gamma-thrombin., Rydel TJ, Yin M, Padmanabhan KP, Blankenship DT, Cardin AD, Correa PE, Fenton JW 2nd, Tulinsky A, J Biol Chem. 1994 Sep 2;269(35):22000-6. PMID:8071320
Page seeded by OCA on Thu Mar 20 17:19:15 2008